On World Pancreatic Cancer Day, a pancreatic cancer patient, oncologist and advocate are renewing the call for a life-sustaining drug called Onivyde to be made available in Canada. As Elizabeth McSheffrey reports, the treatment was approved by Health Canada, but negotiations to distribute it across the country ended in 2019.
Canada
Pancreatic cancer survivor, advocates renew call for life-sustaining drug not available in Canada
More Videos
-
How the climate crisis is affecting Pacific Islanders
-
Nova Scotia’s Africville celebrates UNESCO designation
-
Former Africville residents and descendants receive global recognition
-
Climate preparedness lessons from Fiji apply to Nova Scotia
-
Official UNESCO designation elevates legacy of Africville
-
Mobile vaccine clinics make immunizations more accessible to Nova Scotia newcomers
You are viewing an Accelerated Mobile Webpage.
View Original Article